 Home > Active Ingredient News > Endocrine System > Cardiovasc Diabetol: Sodium-sugar cotransporter inhibitor can significantly reduce the risk of cardiovascular events in patients with T2DM

Cardiovasc Diabetol: Sodium-sugar cotransporter inhibitor can significantly reduce the risk of cardiovascular events in patients with T2DM

 Last Update: 2021-07-27
 Source: Internet
 Author: User

Tags

all gold properties

spices diabetes

what fruits type 2 diabetes

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

About Type 2 diabetes mellitus (T2DM) patients prospectively heart blood vessels results (CV) outcome trials support the use of sodium - glucose cotransporter 2 inhibitor (SGLT2i) T2DM patients to reduce cardiovascular event risk
.

Diabetes, heart blood vessel using sodium - glucose cotransporter 2 inhibitor (SGLT2i) T2DM patients to reduce cardiovascular event risk for cardiovascular events

The CVD-REAL Catalonia trial is a retrospective cohort study that uses real-world data collected daily from 2013 to 2016 to compare SGLT2i and other new users of hypoglycemic drugs (oGLD).
The risk of vascular events
.

According to the propensity score, new users of matched SGLT2i and oGLD were included in a ratio of 1:1
.
The incidence and risk ratio (HR) of all-cause mortality, heart failure hospitalization, chronic kidney disease, and adjusted major adverse CV events (MACE; all-cause mortality, myocardial infarction or stroke ) were compared

Heart failure myocardial infarction stroke

The occurrence of various outcomes of the two groups of subjects

After matching the propensity scores, each group included 12,917 new users
.
About 27% of the subjects had a history of cardiovascular disease

Each group included 12,917 new users with SGLT2i use and lower heart failure (HR 0.

Original source:

Real, J.

Cardiovascular and mortality benefits of sodium--glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia.
Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Estrone53-16-7

CAS No.: 53-16-7

API Grade

$100/KG EXW

Empagliflozin

CAS No.: 864070-44-0

Pharmacy Grade

$1134/KG FOB

Factory wholesale Liraglutide API GLP-1RA weight loss medicine Vict0za, Sαxenda CAS: 204656-20-2

CAS No.: 204656-20-2

Pharmacy Grade

$58-68/G EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.